title: Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
abstract: To conduct a meta-analysis of published data of the effectiveness of drug treatment in giant cell arteritis (GCA) to provide evidence to support the optimal use of glucocorticoids (GCs) and adjunct therapy. MEDLINE, CENTRAL and EMBASE searches were used to identify randomised control trials on the treatment of GCA. Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection. One thousand eight hundred thirty-six articles were retrieved, of which only 37 met the primary inclusion criteria. Sixteen of these studies reported some information about the GCs or adjuvant regimen used. Only ten studies were of sufficient quality to be included in the meta-analysis. Together these comprised 638 participants of which 72 % were female. Three studies compared various GCs regimens, with two comparing IV GCs, the latter showing a marginal benefit with respect to relapse (risk ratio (RR) = 0.78, 95 % CI = 0.54 to 1.12) but a greater risk of infection (RR = 1.58, 95 % CI = 0.90 to 2.78). Another three used methotrexate as an adjunctive agent and showed marginal benefit with respect to relapse (RR = 0.85, 95 % CI = 0.66 to 1.11). The remaining four trials compared prednisolone to dapsone, infliximab, adalimumab and hydroxychloroquine, respectively. There are various clinical trials of varying quality. The results from this meta-analysis show that the use of adjunct agents is not associated with improved outcome.
authors.affiliation: Department of Rheumatology, Norfolk and Norwich University Hospital, Colney Lane, NR4 7UY, UK, maxyates@doctors.org.uk.
authors.forename: M
authors.initials: M
authors.lastname: Yates
authors.forename: Y K
authors.initials: YK
authors.lastname: Loke
authors.forename: R A
authors.initials: RA
authors.lastname: Watts
authors.forename: A J
authors.initials: AJ
authors.lastname: MacGregor
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D003622:Dapsone / Q000008:administration & dosage; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome; D014657:Vasculitis / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; D003622:Dapsone; D011239:Prednisolone; D000069285:Infliximab; D000068879:Adalimumab; D008727:Methotrexate
references.citation: BMJ Case Rep. 2011 Jun 30;2011:
references.pmid: 22693300
references.citation: J Rheumatol. 2011 Jul;38(7):1471-9
references.pmid: 21724719
references.citation: Arthritis Rheum. 1998 Aug;41(8):1497-504
references.pmid: 9704651
references.citation: Ann Intern Med. 1975 May;82(5):613-8
references.pmid: 1137255
references.citation: Rheumatology (Oxford). 2001 Nov;40(11):1238-42
references.pmid: 11709607
references.citation: Arthritis Rheum. 2007 Aug;56(8):2789-97
references.pmid: 17665429
references.citation: Arthritis Rheum. 2012 Nov;64(11):3788-98
references.pmid: 22833233
references.citation: Ann Intern Med. 2001 Jan 16;134(2):106-14
references.pmid: 11177313
references.citation: Ann Rheum Dis. 2006 Aug;65(8):1093-8
references.pmid: 16414971
references.citation: Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501
references.pmid: 11579707
references.citation: Arthritis Rheum. 2012 Jun;64(6):2001-11
references.pmid: 22147555
references.citation: Acta Med Scand. 1981;209(5):347-50
references.pmid: 7246270
references.citation: Rheumatology (Oxford). 2012 Jan;51(1):151-6
references.pmid: 22075063
references.citation: J Rheumatol. 2000 Jun;27(6):1484-91
references.pmid: 10852275
references.citation: Proc Staff Meet Mayo Clin. 1950 Aug 16;25(17):492-4
references.pmid: 15440931
references.citation: Arthritis Rheum. 2006 Oct;54(10):3310-8
references.pmid: 17009270
references.citation: Ann Rheum Dis. 2013 Sep 1;72(9):1481-7
references.pmid: 22993227
references.citation: Arthritis Rheum. 2002 May;46(5):1309-18
references.pmid: 12115238
references.citation: J Clin Epidemiol. 2006 Jan;59(1):7-10
references.pmid: 16360555
references.citation: Am J Med. 1996 Feb;100(2):193-6
references.pmid: 8629654
references.citation: J Am Med Assoc. 1957 Mar 9;163(10):821-7
references.pmid: 13405740
references.citation: Swiss Med Wkly. 2011 Jan 17;141:w13156
references.pmid: 21243547
references.citation: Arthritis Rheum. 2003 Oct 15;49(5):703-8
references.pmid: 14558057
references.citation: Circulation. 2010 Feb 23;121(7):906-15
references.pmid: 20142449
references.citation: Ann Rheum Dis. 1986 Feb;45(2):136-8
references.pmid: 3511861
references.citation: Ann Rheum Dis. 2008 May;67(5):625-30
references.pmid: 18086726
references.citation: Ann Rheum Dis. 2014 Dec;73(12):2074-81
references.pmid: 23897775
references.citation: Ann Rheum Dis. 2009 Mar;68(3):318-23
references.pmid: 18413441
references.citation: J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1255-9
references.pmid: 17504884
references.citation: Ann Intern Med. 2007 May 1;146(9):621-30
references.pmid: 17470830
references.citation: Br J Rheumatol. 1998 Apr;37(4):464-5
references.pmid: 9619904
references.citation: Rheumatology (Oxford). 2010 Aug;49(8):1594-7
references.pmid: 20371504